loadpatents
name:-0.031358957290649
name:-0.016155004501343
name:-0.0076310634613037
RAYMON; Heather Patent Filings

RAYMON; Heather

Patent Applications and Registrations

Patent applications and USPTO patent grants for RAYMON; Heather.The latest application filed is for "treatment of cancer with tor kinase inhibitors".

Company Profile
7.17.25
  • RAYMON; Heather - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment Of Cancer With Tor Kinase Inhibitors
App 20220273650 - XU; Shuichan ;   et al.
2022-09-01
Cd47 Antibodies And Methods Of Use Thereof
App 20210371522 - Sung; Victoria ;   et al.
2021-12-02
Treatment of cancer with TOR kinase inhibitors
Grant 11,166,950 - Xu , et al. November 9, 2
2021-11-09
Substituted Aminopurine Compounds, Compositions Thereof, And Methods Of Treatment Therewith
App 20210128565 - Alexander; Matthew ;   et al.
2021-05-06
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
Grant 10,940,152 - Alexander , et al. March 9, 2
2021-03-09
Cd47 Antibodies And Methods Of Use Thereof
App 20200255515 - Kind Code
2020-08-13
Substituted Aminopurine Compounds, Compositions Thereof, And Methods Of Treatment Therewith
App 20200237768 - Alexander; Matthew ;   et al.
2020-07-30
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
Grant 10,646,493 - Alexander , et al.
2020-05-12
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
Grant 10,576,085 - Boylan , et al.
2020-03-03
Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
Grant 10,391,092 - Raymon , et al. A
2019-08-27
Treatment of cancer with dihydropyrazino-pyrazines
Grant 10,183,019 - Raymon , et al. Ja
2019-01-22
Treatment Of Cancer With Tor Kinase Inhibitors
App 20180235960 - XU; Shuichan ;   et al.
2018-08-23
Methods For Treating Cancer Using Dihydropyrazino-pyrazine Compound Combination Therapy
App 20180185361 - RAYMON; HEATHER ;   et al.
2018-07-05
Treatment of cancer with dihydropyrazino-pyrazines
Grant 9,980,963 - Raymon , et al. May 29, 2
2018-05-29
Treatment of cancer with TOR kinase inhibitors
Grant 9,937,170 - Xu , et al. April 10, 2
2018-04-10
Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
Grant 9,937,169 - Raymon , et al. April 10, 2
2018-04-10
Methods for treating cancer using TOR kinase inhibitor combination therapy
Grant 9,782,427 - Raymon October 10, 2
2017-10-10
Substituted Aminopurine Compounds, Compositions Thereof, And Methods Of Treatment Therewith
App 20170281633 - Boylan; John F. ;   et al.
2017-10-05
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
Grant 9,737,541 - Alexander , et al. August 22, 2
2017-08-22
Treatment Of Cancer With Dihydropyrazino-pyrazines
App 20170182044 - RAYMON; HEATHER ;   et al.
2017-06-29
Treatment of cancer with dihydropyrazino-pyrazines
Grant 9,630,966 - Raymon , et al. April 25, 2
2017-04-25
Treatment Of Cancer With Dihydropyrazino-pyrazines
App 20170065583 - RAYMON; HEATHER ;   et al.
2017-03-09
Substituted Aminopurine Compounds, Compositions Thereof, And Methods Of Treatment Therewith
App 20170042902 - Alexander; Matthew ;   et al.
2017-02-16
Treatment Of Cancer With Tor Kinase Inhibitors
App 20170027932 - XU; Shuichan ;   et al.
2017-02-02
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
Grant 9,512,124 - Alexander , et al. December 6, 2
2016-12-06
Treatment of cancer with dihydropyrazino-pyrazines
Grant 9,505,764 - Raymon , et al. November 29, 2
2016-11-29
Treatment of cancer with TOR kinase inhibitors
Grant 9,493,466 - Xu , et al. November 15, 2
2016-11-15
Substituted Aminopurine Compounds, Compositions Thereof, And Methods Of Treatment Therewith
App 20160096841 - Alexander; Matthew ;   et al.
2016-04-07
Treatment Of Cancer With Dihydropyrazino-pyrazines
App 20140314674 - RAYMON; HEATHER ;   et al.
2014-10-23
Treatment Of Cancer With Dihydropyrazino-pyrazines
App 20140314673 - RAYMON; HEATHER ;   et al.
2014-10-23
Methods For Treating Cancer Using Dihydropyrazino-pyrazine Compound Combination Therapy
App 20140315900 - RAYMON; HEATHER ;   et al.
2014-10-23
Treatment Of Cancer With Dihydropyrazino-pyrazines
App 20140315907 - RAYMON; HEATHER ;   et al.
2014-10-23
Methods For Treating Cancer Using Tor Kinase Inhibitor Combination Therapy
App 20140315848 - RAYMON; HEATHER
2014-10-23
Treatment Of Cancer With Tor Kinase Inhibitors
App 20140113904 - Mortensen; Deborah ;   et al.
2014-04-24
Methods of treatment, improvement and prevention using haloaryl substituted aminopurines
Grant 8,680,076 - Bennett , et al. March 25, 2
2014-03-25
Treatment Of Cancer With Tor Kinase Inhibitors
App 20130245028 - Xu; Shuichan ;   et al.
2013-09-19
Treatment Of Cancer With Tor Kinase Inhibitors
App 20130245027 - Xu; Shuichan ;   et al.
2013-09-19
Treatment Of Cancer With Tor Kinase Inhibitors
App 20130245026 - Xu; Shuichan ;   et al.
2013-09-19
Treatment Of Cancer With Tor Kinase Inhibitors
App 20130102613 - XU; SHUICHAN ;   et al.
2013-04-25
Methods Of Treatment, Improvement And Prevention Using Haloaryl Substituted Aminopurines
App 20120129807 - Bennett; Brydon L. ;   et al.
2012-05-24
Pyrazole Pyrazine Amine Compounds As Kinase Inhibitors, Compositions Thereof And Methods Of Treatment Therewith
App 20090270418 - Sloss; Marianne ;   et al.
2009-10-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed